INTCO Medical Defies Market Slump with Record 2025 Revenue

ZIBO, China – April 29, 2026 – In a year that saw the global medical glove industry grapple with a severe post-pandemic correction, INTCO Medical has announced a landmark financial performance for 2025. The company reported revenue reaching RMB 9.93 billion (approximately US$1.46 billion), a 4.23% year-over-year increase and a four-year high, signaling remarkable resilience in a turbulent market.

While many manufacturers struggled against headwinds of oversupply and plummeting prices, INTCO posted a net profit of RMB 1.01 billion (US$148.03 million). The company's strategic maneuvering also led to a 15.77% growth in total assets, which now exceed RMB 40 billion (US$5.86 billion), and a 74.69% surge in net cash flow from operations. This robust financial health stands in stark contrast to the mixed and often negative results seen elsewhere in the sector.

Navigating a Post-Pandemic Market Correction

The term “industry rebalancing,” as noted in the company's report, understates the profound challenges the medical supply sector faced in 2025. The market was still reeling from the demand bubble created by the COVID-19 pandemic, which led to massive capacity expansions. The subsequent normalization resulted in a significant global oversupply of disposable gloves.

This glut sent average selling prices (ASPs) into a freefall. After peaking above US$50 per 1,000 pieces during the pandemic, ASPs cratered to near-historic lows of around US$20 throughout 2024 and 2025. Compounding the issue were volatile raw material costs, particularly for nitrile butadiene rubber (NBR), and shifting geopolitical tides, including US tariffs on Chinese-made gloves that were set at 50% in 2025 with plans to increase further.

Amid these challenges, a structural shift in the market continued, with a pronounced move away from natural rubber latex towards synthetic alternatives to mitigate allergy risks. Nitrile gloves, a core product for INTCO, solidified their dominance, capturing nearly 48% of the market share in 2025. INTCO's ability to not only survive but thrive in this environment points to a highly effective operational and strategic playbook.

A Landscape of Divergent Fortunes

INTCO’s success was not a reflection of a universally rising tide. The 2025 financial year painted a picture of sharply divergent outcomes for major global glove manufacturers. While some competitors managed a recovery, others continued to struggle.

Malaysia's Top Glove, the world's largest producer by volume, returned to profitability after two years of losses, attributing its rebound to stronger demand and cost efficiencies. Hartalega Holdings also saw its net profit multiply due to cost optimization, though it continued to warn of persistent overcapacity. In contrast, Supermax Corporation reported a substantial net loss for its 2025 fiscal year, citing lower margins and sales volumes, particularly from the US market.

This varied landscape underscores the effectiveness of INTCO's strategy. While others were forced into purely defensive postures, INTCO leveraged its scale and efficiency to capture growth. With an annualized production capacity of 103 billion non-latex gloves, including 70 billion nitrile gloves, the company's massive manufacturing footprint provided a critical competitive advantage.

Innovation and Global Reach as Growth Pillars

A key driver of INTCO's performance was its unwavering commitment to innovation, backed by a significant R&D investment of RMB 404 million (US$59.21 million) in 2025. This figure, representing 4.07% of its revenue, is considerably above the industry average and fueled the development of new materials and products.

The launch of innovative products like Syntex™ Synthetic Disposable Latex Gloves and Synmax Pro Exam Gloves demonstrates a proactive approach to market trends. By developing proprietary synthetic alternatives, the company is catering to the growing demand for high-performance, non-allergenic products and building a defensible technological moat.

Furthermore, INTCO has aggressively pursued a global development strategy to enhance its supply chain resilience and market access. The company operates 10 R&D and manufacturing bases worldwide and is expanding its overseas production capacity, with new facilities in Vietnam. This geographic diversification is a strategic hedge against geopolitical risks and trade policy uncertainties, allowing for more stable delivery and better responsiveness to regional demand for its network of over 15,000 customers across 150 countries.

Beyond the Glove: A Vision for Diversified Healthcare

While disposable gloves remain its core business, INTCO is strategically looking beyond a single product category to build a more balanced and resilient business model. The company is actively growing its other segments, including rehabilitation medical equipment and physical therapy services.

This diversification is not just a defensive move against the volatility of the glove market; it represents a forward-looking vision for a more integrated role in the healthcare ecosystem. By expanding its portfolio, INTCO is positioning itself to capture value across different segments of patient care.

This long-term vision is complemented by a strong focus on sustainability. The company reported generating 12,537.23 MWh of clean energy from its wind and solar projects in 2025. This is more than a public relations talking point; it is a critical business imperative. With Environmental, Social, and Governance (ESG) criteria increasingly accounting for up to one-fifth of the score in major procurement tenders, a demonstrable commitment to sustainable practices provides a tangible competitive advantage. By integrating advanced automation, digital AI tools, and green energy, INTCO is building a manufacturing operation that is not only efficient but also aligned with the future of global healthcare supply chain requirements.